A Working Group of 17 scientists from 10 countries met at the International Agency for Research on Cancer (IARC) on 21-28 March 2016 to evaluate the carcinogenicity of welding, molybdenum trioxide, and indium tin oxide. A summary of the evaluations has now been published in The Lancet Oncology. The detailed assessments will be published as Volume 118 of the IARC Monographs.
Guha N, Loomis D, Guyton KZ, Grosse Y, El Ghissassi F, Bouvard V, et al.
Carcinogenicity of welding, molybdenum trioxide, and indium tin oxide
Lancet Oncol, Published online 10 April 2017; http://ift.tt/2o2bqEt
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2omqZZY
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Caring for Patients with Physical Disabilities: Assessment of an Innovative Spinal Cord Injury Session that Addresses an Educational Gap Des...
-
Abstract Objective To study the effects of Astragalus polysaccharide (APS), the primary effective component of the Chinese herb medicine A...
-
Geriatric trauma: A population-based study Saint Shiou-Sheng Chen, Li-Chien Chien Formosan Journal of Surgery 2019 52(2):39-44 Background: G...
-
Related Articles Disrupted relationship between "resting state" connectivity and task-evoked activity during social percepti...
-
Pharmacogenomics in palliative medicine Mahadev Rao Indian Journal of Palliative Care 2019 25(2):169-171 A survey of medical professionals i...
-
World Community; and Remarks on our Own Behalf Models of Anticipation Within the Responsible Research and Innovation Framework: the Two RRI ...
-
Abstract Eslicarbazepine acetate is a new anti-epileptic drug belonging to the dibenzazepine carboxamide family that is currently approved ...
-
Related Articles Randomized clinical trial of percutaneous tibial nerve stimulation versus sham electrical stimulation in patients wit...
-
Objective Outpatient parenteral antimicrobial therapy (OPAT) provides opportunities for improved cost savings, but in the UK, implementation...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου